← Back to front page
United States · Wires & real time · Bloomberg

Denmark’s Leo Pharma Delays IPO Plans Beyond 2026, CEO Says

Published by Bloomberg · United States 52 min ago

Detailed summary

Leo Pharma A/S is delaying plans for an initial public offering beyond 2026, pushing back a listing it had previously targeted for this year.

Read the full article on Bloomberg Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.bloomberg.com)

Also worth reading